课题基金 / 基金详情

Enamel-derived modulators of biomineralization

Enamel-derived modulators of biomineralization
牙釉质衍生的生物矿化调节剂
批准号:
RGPIN-2019-07070
负责人:
Ganss, Bernhard
金额:
$2.62万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-01-01 至 2021-12-31

项目摘要

项目成果

Ganss, Bernhard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Biomineralization is the basis for formation and maintenance of such important organs as bones and teeth, but the detailed mechanisms of this process are poorly understood. We have earlier identified amelotin (AMTN) as an enamel-specific protein and have demonstrated during the previous grant tenure that AMTN promotes the formation of hydroxyapatite (HA), the mineral of bones and teeth. The overarching goal of this proposal is to optimize and harness the mineral-inducing properties of AMTN for remineralization of enamel and other mineralized tissues. Background: The bulk of dental enamel is formed in an acellular organic matrix consisting predominantly (90%) of the phosphorylated protein amelogenin (AMEL). This matrix guides the formation of a highly organized interwoven network of HA crystal rods, which give enamel its remarkable mechanical properties. The surface of enamel, however, is structurally distinct, fully mineralized and compact, and resembles a mineral "varnish" layer rather than a mineralized mesh work. The localization of AMTN coincides perfectly with the formation of this enamel surface layer. We have demonstrated in extensive recent work that AMTN promotes HA in enamel, but also in other mineralized tissue. We have also shown that phosphorylation of AMTN-derived peptides can enhance their mineral-promoting properties. Based on this work, the current proposal has three main objectives as follows: 1. Evaluate the role of AMTN serine phosphorylation in promoting mineralization We will optimize protocols for the recombinant production of AMTN that is phosphorylated at evolutionary conserved serine residues (pAMTN). The mineral inducing properties of pAMTN will be determined in vitro and compared with those of unmodified AMTN, which we already produce routinely. 2. Produce HA nanoparticles that include AMTN protein or peptides We will produce small HA nanoparticles as carriers for AMTN and derived peptides, both in unmodified and phosphorylated versions, and characterize them in detail. We expect these nanoparticles to enhance the mineral-promoting properties of AMTN and peptides, integrate more readily into pre-existing mineral and prolong the shelf-life of proteins and peptides. 3. Test the mineral-inducing properties of AMTN-HA nanoparticles in vitro and in vivo HA-AMTN nanoparticles will be applied to enamel lesions and demineralized dentin obtained from extracted teeth in vitro. Similarly, demineralized rat molar enamel and calvarial bones will be treated with HA-AMTN nanoparticles to evaluate their effect in vivo. The degree of remineralization and the extent and nature of the mineral formed will be determined. Significance: If successful, the defined mineral-inducing properties of HA-AMTN nanoparticles will be widely applicable to achieve remineralization and integration of restorative and implant materials into mineralized tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enamel-derived modulators of biomineralization
  • 批准号:
    RGPIN-2019-07070
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2022
  • 负责人:
    Ganss, Bernhard
  • 依托单位:
Enamel-derived modulators of biomineralization
  • 批准号:
    RGPIN-2019-07070
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2021
  • 负责人:
    Ganss, Bernhard
  • 依托单位:
Enamel-derived modulators of biomineralization
  • 批准号:
    RGPIN-2019-07070
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2019
  • 负责人:
    Ganss, Bernhard
  • 依托单位:
Novel Enamel Proteins for Biomineralization Applications
  • 批准号:
    RGPIN-2018-06898
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2018
  • 负责人:
    Ganss, Bernhard
  • 依托单位:
国内基金
海外基金
tRNA-derived small RNA上调YBX1/CCL5通路参与硼替佐米诱导慢性疼痛的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    张祥忠
  • 依托单位:
一类DMOA-Derived Meroterpenoid的全合成研究
  • 批准号:
    22071192
  • 项目类别:
    面上项目
  • 资助金额:
    63.0万元
  • 批准年份:
    2020
  • 负责人:
    胡向东
  • 依托单位:
TET1/exosome-derived miR-22-3p/BTG1信号轴在膀胱癌化疗耐药中的作用与分子机制
  • 批准号:
    82072807
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    肖峻
  • 依托单位:
基于寨卡病毒NS1和NS5的海洋微生物中抗病毒化合物的发现
  • 批准号:
    81973204
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2019
  • 负责人:
    宋福行
  • 依托单位: